Product Information

HYDROCODONE-ACETAMINOPHEN 5-325 MG TABLET is a generic product labeled by Elite Laboratories, Inc., priced at $0.1292 per EA under NDC 64850063101. Its NADAC has been published 77 times since Jun 4, 2025.

FDA first approved this application on Nov 16, 2018. Its Orange Book therapeutic-equivalence code is AA.

HYDROCODONE-ACETAMINOPHEN 5-325 MG TABLET

Hydrocodone Bitartrate and Acetaminophen
$0.1292per EA
DEA Schedule CII

Strength

325; 5 mg/1; mg/1

NDC

64850063101

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

11/18/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA209924

FDA Approved

11/16/2018

TE Code

AA

On Market Since

11/16/2018

Pharmacological Classes

Opioid Agonist
Opioid Agonists

Price Statistics

The NADAC for HYDROCODONE-ACETAMINOPHEN 5-325 MG TABLET has been published 77 times since Jun 4, 2025, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.

Current price$0.1292 per EA
All-time high$0.1388 (Aug 12, 2026)
All-time low$0.1273 (Sep 17, 2025)
52-week high$0.1388
52-week low$0.1276
Median price$0.1298
Average price$0.1313
Largest weekly change+3.1% (Jun 17, 2026)
Weeks tracked77
Tracking sinceJun 4, 2025

Price History

1W

-2.1%

1M

-5.1%

3M

-6.7%

6M

-1.4%

1Y

+1.2%

3Y

N/A

5Y

N/A

All

+0.2%

Generic Alternatives

The matcher finds 11 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 18% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of HYDROCODONE-ACETAMINOPHEN 5-325 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for HYDROCODONE-ACETAMINOPHEN 5-325 MG TABLET, manufactured by Elite Laboratories, Inc., is $0.1292 per EA (NDC 64850063101), effective Nov 18, 2026.

How has the price of HYDROCODONE-ACETAMINOPHEN 5-325 MG TABLET changed over time?

Over the history we have for it, the NADAC for HYDROCODONE-ACETAMINOPHEN 5-325 MG TABLET has held within roughly two percent of its current level. It has been tracked across 77 weekly CMS publications since Jun 4, 2025.

What are the highest and lowest recorded NADAC prices for HYDROCODONE-ACETAMINOPHEN 5-325 MG TABLET?

Since Jun 4, 2025, the NADAC for HYDROCODONE-ACETAMINOPHEN 5-325 MG TABLET has ranged from a low of $0.1273 (Sep 17, 2025) to a high of $0.1388 (Aug 12, 2026), with a median of $0.1298 per EA.

Are there cheaper alternatives to HYDROCODONE-ACETAMINOPHEN 5-325 MG TABLET?

Yes. 11 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, HYDROCODONE-ACETAMINOPHEN 5-325 MG TABLET, is $0.1066 per EA — about 18% below HYDROCODONE-ACETAMINOPHEN 5-325 MG TABLET.

Who manufactures HYDROCODONE-ACETAMINOPHEN 5-325 MG TABLET?

HYDROCODONE-ACETAMINOPHEN 5-325 MG TABLET (NDC 64850063101) is labeled by Elite Laboratories, Inc., and CMS classifies it as a generic product.